Simplex Trading’s OncoMed Pharmaceuticals OMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
– Sell
-60
Closed -$13K – 8657
2018
Q2
$13K Sell
60
-63
-51% -$183 ﹤0.01% 6201
2018
Q1
$2K Buy
123
+31
+34% +$85 ﹤0.01% 5501
2017
Q4
$3K Buy
+92
New +$400 ﹤0.01% 5090
2017
Q3
– Sell
-34
Closed -$1K – 7311
2017
Q2
$1K Buy
34
+19
+127% +$79 ﹤0.01% 5951
2017
Q1
$2K Sell
15
-65
-81% -$571 ﹤0.01% 5494
2016
Q4
$3K Buy
80
+58
+264% +$533 ﹤0.01% 4947
2016
Q3
$1K Sell
22
-36
-62% -$419 ﹤0.01% 5672
2016
Q2
$7K Buy
58
+43
+287% +$522 ﹤0.01% 4017
2016
Q1
$2K Sell
15
-3
-17% -$35 ﹤0.01% 4968
2015
Q4
$7K Buy
+18
New +$369 ﹤0.01% 3691
2015
Q2
– Sell
-195
Closed -$83K – 6560
2015
Q1
$83K Buy
195
+145
+290% +$3.68K 0.01% 1213
2014
Q4
$15K Buy
+50
New +$1.02K ﹤0.01% 2300

Other funds holding OMED

Simplex Trading's OMED Position: Q1 2019 in Review

Simplex Trading sold out of OncoMed Pharmaceuticals (OMED) in Q1 2019, closing a stake of 15 shares.

Simplex Trading first reported a position in OMED in Q2 2015 and held it in 14 quarters. The position peaked at $344K in Q1 2017. 41 funds tracked by Wall St. Rank hold OMED as of Q1 2019.

  • Simplex Trading reported no remaining OncoMed Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • Simplex Trading sold 15 OncoMed Pharmaceuticals shares in Q1 2019.
  • Simplex Trading first reported a position in OncoMed Pharmaceuticals in Q2 2015 and held it in 14 quarters.
  • Simplex Trading's OncoMed Pharmaceuticals position peaked at $344K in Q1 2017.
  • 41 funds tracked by Wall St. Rank held OncoMed Pharmaceuticals as of Q1 2019.

Based on Simplex Trading's 13F filing for Q1 2019, filed 18 Apr 2019.